In a filing, Schrodinger Inc revealed its President of R&D, Therapeutics Akinsanya Karen unloaded Company’s shares for reported $0.42 million on Apr 14 ’25. In the deal valued at $25.09 per share,16,723 shares were sold. As a result of this transaction, Akinsanya Karen now holds 15,625 shares worth roughly $0.41 million.
Then, Karen Akinsanya bought 16,723 shares, generating $409,546 in total proceeds.
Before that, Herman Jenny sold 666 shares. Schrodinger Inc shares valued at $14,059 were divested by the SVP & Controller at a price of $21.11 per share. As a result of the transaction, Herman Jenny now holds 27,349 shares, worth roughly $0.71 million.
Leerink Partners initiated its Schrodinger Inc [SDGR] rating to an Outperform in a research note published on July 02, 2024; the price target was $29. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who began to cover the stock in early December with a ‘”an Overweight”‘ rating. Goldman started covering the stock on December 19, 2022. It rated SDGR as “a Neutral”.
Price Performance Review of SDGR
On Tuesday, Schrodinger Inc [NASDAQ:SDGR] saw its stock jump 2.59% to $26.13. Over the last five days, the stock has gained 14.10%. Schrodinger Inc shares have risen nearly 35.46% since the year began. Nevertheless, the stocks have risen 11.67% over the past one year.
How much short interest is there in Schrodinger Inc?
A steep rise in short interest was recorded in Schrodinger Inc stocks on 2025-05-15, dropping by -0.39 million shares to a total of 10.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 10.61 million shares. There was a decline of -3.81%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 01, 2022 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $55 price target.
